Here are the latest quarterly results of FACT. For more details, see the FACT financial fact sheet and FACT share price and chart.
No. of Mths Qtr. Ending |
3
Dec-12 |
3
Mar-13 |
3
Jun-13 |
3
Sep-13 |
3
Dec-13 |
3
Mar-14 |
3
Jun-14 |
3
Mar-15 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 6,775 | 4,089 | 3,070 | 7,128 | 8,067 | 4,982 | 3,933 | 4,768 | |
Other income | Rs m | 20 | 3 | 16 | 16 | 16 | -23 | 12 | 17 | |
Turnover | Rs m | 6,795 | 4,092 | 3,086 | 7,144 | 8,083 | 4,959 | 3,944 | 4,786 | |
Expenses | Rs m | 7,090 | 4,926 | 3,681 | 7,323 | 7,401 | 5,146 | 4,230 | 5,241 | |
Gross profit | Rs m | -315 | -836 | -610 | -195 | 666 | -164 | -298 | -473 | |
Depreciation | Rs m | 115 | 128 | 110 | 110 | 107 | 126 | 120 | 58 | |
Interest | Rs m | 388 | 480 | 295 | 542 | 422 | 660 | 474 | 521 | |
Profit before tax | Rs m | -798 | -1,441 | -999 | -831 | 153 | -973 | -881 | -1,033 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -798 | -1,441 | -999 | -831 | 153 | -973 | -881 | -1,033 | |
Gross profit margin | % | -4.6 | -20.4 | -19.9 | -2.7 | 8.3 | -3.3 | -7.6 | -9.9 | |
Effective tax rate | % | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
Net profit margin | % | -11.8 | -35.2 | -32.5 | -11.7 | 1.9 | -19.5 | -22.4 | -21.7 | |
Diluted EPS | Rs | -1.2 | -2.2 | -1.5 | -1.3 | 0.2 | -1.5 | -1.4 | -1.6 | |
Diluted EPS (TTM) | Rs | -2.7 | -5.5 | -5.4 | -6.3 | -4.8 | -4.1 | -3.9 | -4.2 | |
![]() |
More Fertilizers Company Quarterly Results: ZUARI GLOBAL TATA CHEMICALS MANGALORE CHEMICALS COROMANDEL INTERN NATIONAL FERT
Compare FACT With: ZUARI GLOBAL TATA CHEMICALS MANGALORE CHEMICALS COROMANDEL INTERN NATIONAL FERT
The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.
Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More